Inhaled steroids help manage asthma symptoms and should be used daily as prescribed. Different types of inhaled corticosteroids include Alvesco, Pulmicort, and Qvar. Combining a steroid inhaler with a ...

U.S. Senator Maggie Hassan (D-NH) is intensifying her scrutiny of GSK Plc (NYSE:GSK) over the company's decision to pull its widely used asthma inhaler, Flovent HFA, from the market. One year after ...

The go-to asthma inhaler prescribed by pediatricians for decades has been discontinued, and patients and families are paying a steep price. Discontinued Inhaler Devastates Families On Jan. 10, Laura ...

There’s a big change coming for asthma sufferers, starting on January 1. On Monday, Flovent, a widely used asthma inhaler made by GSK, will no longer be available in U.S. pharmacies. In its place will ...

USA: Results from a randomized clinical trial showed that Alvesco (ciclesonide, Covis Pharma) did not achieve the primary efficacy endpoint of a reduced time to alleviation of all COVID-19–related ...

COVID-19 outpatients treated with the inhaled corticosteroid ciclesonide (Alvesco) obtained no symptom relief beyond that seen in a placebo group, a large randomized trial showed. Odds of needing ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Nonhospitalized patients with COVID-19 who received the ...

UK: AstraZeneca has recently announced that the company has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) ...

AstraZeneca said on Monday it will transfer global rights for respiratory medicines Eklira and Duaklir to Covis Pharma Group for $270 million, as the Anglo-Swedish drugmaker looks to offload its older ...

Nov 1 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday it will transfer global rights for respiratory medicines Eklira and Duaklir to Covis Pharma Group for $270 million, as the ...